Accordingly, we hypothesized that GATA2 downregulation may disrupt the macrophage phagocytosis and aggravate pulmonary inflammation by enhancing the expression of pro-inflammatory cytokines in macrophages during COPD development. This evidence concerns the gene GATA2 and chronic obstructive pulmonary disease.